Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Apr 22, 2024 DEFA14A
DEF 14A Apr 22, 2024 DEF 14A
4/A Apr 17, 2024 4/A
4/A Apr 17, 2024 4/A
4 Apr 8, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Apr 3, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Mar 28, 2024 CURRENT REPORT
UPLOAD Mar 13, 2024
4 Mar 12, 2024 4
4 Mar 12, 2024 4
4 Mar 12, 2024 4
144 Mar 12, 2024
144 Mar 11, 2024
144 Mar 11, 2024
144 Mar 11, 2024
S-3 Mar 7, 2024 S-3
S-8 Mar 7, 2024 S-8
S-8 POS Mar 7, 2024 S-8 POS
10-K Mar 7, 2024 10-K
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G Feb 13, 2024 SCHEDULE 13G
8-K Feb 13, 2024 ALDEYRA THERAPEUTICS, INC. 8-K
SC 13G Jan 29, 2024
8-K Jan 4, 2024 ALDEYRA THERAPEUTICS, INC. 8-K
8-K Dec 21, 2023 8-K
← Newer Page 5 of 26 · 646 filings Older →